(Q54171002)

25 May 2018

title

Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. (English)

1 reference

25 May 2018

main subject

myocardial infarction

1 reference

acute myocardial infarction

inferred from title

1 reference

4

Michael Wolzt

1 reference

25 May 2018

author name string

Ghazaleh Gouya

series ordinal

1

1 reference

25 May 2018

Berthold Reichardt

series ordinal

2

1 reference

25 May 2018

Gerald Ohrenberger

series ordinal

3

1 reference

25 May 2018

publication date

14 March 2007

1 reference

25 May 2018

European Journal of Epidemiology

published in

1 reference

25 May 2018

volume

22

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

145-149

1 reference

25 May 2018

https://scigraph.springernature.com/pub.10.1007/s10654-006-9087-9

exact match

0 references

cites work

Coronary heart disease trends in four United States communities. The Atherosclerosis Risk in Communities (ARIC) study 1987-1996.

1 reference

https://api.crossref.org/works/10.1007%2FS10654-006-9087-9

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-006-9087-9

beta Blockade after myocardial infarction: systematic review and meta regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-006-9087-9

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-006-9087-9

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the M

21 January 2018

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Incidence of myocardial infarction in the Danish MONICA population 1982-1991.

1 reference

12 December 2020

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

1 reference

12 December 2020

One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry)

1 reference

12 December 2020

Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes

1 reference

12 December 2020

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

12 December 2020

Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)**Further information about the project, along with a complete list

1 reference

12 December 2020

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

1 reference

12 December 2020

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

1 reference

12 December 2020

Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.

1 reference

12 December 2020

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

12 December 2020

Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey

1 reference

12 December 2020

Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence

1 reference

12 December 2020

10.1007/S10654-006-9087-9

Identifiers

DOI

1 reference

25 May 2018

PubMed ID

17356927

1 reference

25 May 2018